REGENERON PHARMACEUTICALS, INC. cotiza a 753.12 USD y tiene una capitalización bursátil de $77.5B. En los últimos 12 meses ha facturado $15.5B con un margen de flujo de caja libre del 28.4%. Cotiza a 20.6 veces su flujo de caja libre (P/FCF) y a un PER de 17.9. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic c…
| Periodo | 2026-10 | 2026-07 | 2026-04 | 2026-01 |
|---|---|---|---|---|
| Real | — | $14.29 | $9.47 | $11.44 |
| Estimado | $16.07 | $10.21 | $8.90 | $10.75 |
| Sorpresa | — | +40.0% | +6.4% | +6.4% |
| Métrica | REGN | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | 24.9% | -38.6% | +63.6% |
| Net Margin | 31.4% | -33.6% | +65.0% |
| FCF Margin | 28.4% | -13.9% | +42.3% |
| ROE | 14.4% | -40.4% | +54.8% |
| ROA | 11.1% | -32.0% | +43.1% |
| Current Ratio | 4.13 | 2.84 | +1.29 |
| Debt / Equity | 0.06 | 0.28 | -0.22 |